Patent wars: what’s behind Amgen’s possible win over Sanofi at the US Supreme Court
Pharmaceutical Technology
FEBRUARY 22, 2023
Not even two weeks ago, the likes of AstraZeneca and Pfizer voiced their support of Sanofi’s side through amicus briefs submitted to the Court. Both drugs come with a high price tag. Due to this, Contreras has signed an amicus brief in support of Amgen. Both drugs are monoclonal antibodies that inhibit the protein PCSK9.
262 
Let's personalize your content